LASIX

This brand name is authorized in United States. It is also authorized in Australia, Austria, Brazil, Canada, Croatia, Cyprus, Ecuador, Estonia, Germany, Hong Kong SAR China, Ireland, Italy, Japan, Lithuania, Mexico, Netherlands, New Zealand, Singapore, South Africa, Turkey.

Active ingredients

The drug LASIX contains one active pharmaceutical ingredient (API):

1	Furosemide UNII 7LXU5N7ZO5 - FUROSEMIDE
	Furosemide inhibits active chloride transport in the thick ascending limb. Re-absorption of sodium, chloride from the nephron is reduced and a hypotonic or isotonic urine produced. The evidence from many experimental studies suggests that furosemide acts along the entire nephron with the exception of the distal exchange site.
	Read more about Furosemide

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
LASIX Solution for injection or infusion	MPI, EU: SmPC	Health Products Regulatory Authority (IE)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C03CA01	Furosemide	C Cardiovascular system → C03 Diuretics → C03C High-ceiling diuretics → C03CA Sulfonamides, plain
Discover more medicines within C03CA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	12222G, 1810G, 2411X, 2412Y, 2413B, 3466K
BR	Câmara de Regulação do Mercado de Medicamentos	502807301157313, 502807302110310, 576720040061617, 576720040061717
CA	Health Products and Food Branch	02224720, 02224755
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	01097929, 01463535, 01463541, 01595774, 02510969, 04686276, 04686299
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	28797-03-09
EE	Ravimiamet	1039362, 1738245, 1825321
HK	Department of Health Drug Office	05565, 05566, 59962
HR	Agencija za lijekove i medicinske proizvode	HR-H-797987648
IE	Health Products Regulatory Authority	30856
IT	Agenzia del Farmaco	020465011, 023993013, 023993037, 023993049
JP	医薬品医療機器総合機構	2139005F1052, 2139005F2342, 2139005F3039, 2139401A1033, 2139401A2137
LT	Valstybinė vaistų kontrolės tarnyba	1003666, 1015558, 1086333
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	62267, 62270
NL	Z-Index G-Standaard, PRK	20877, 33936
NZ	Medicines and Medical Devices Safety Authority	315, 317
SG	Health Sciences Authority	00199P
TR	İlaç ve Tıbbi Cihaz Kurumu	8699809014008, 8699809018754, 8699809754003, 8699809759206, 8699809759213
US	FDA, National Drug Code	30698-060, 30698-066, 30698-067
ZA	Health Products Regulatory Authority	D/18.1/266, E/18.1/201, E/18.1/202, J/18.1/5, N/18.1/6, V/18.1/9